| Literature DB >> 33808153 |
Patricia Ruiz-Iglesias1,2, Abril Gorgori-González1, Malén Massot-Cladera1,2, Margarida Castell1,2,3, Francisco J Pérez-Cano1,2.
Abstract
Flavonoids are attracting increasing attention due to their antioxidant, cardioprotective, and immunomodulatory properties. Nevertheless, little is known about their role in exercise performance in association with immune function. This systematic review firstly aimed to shed light on the ergogenic potential of flavonoids. A search strategy was run using SCOPUS database. The returned studies were screened by prespecified eligibility criteria, including intervention lasting at least one week and performance objectively quantified, among others. Fifty-one studies (54 articles) met the inclusion criteria, involving 1288 human subjects, either physically untrained or trained. Secondly, we aimed to associate these studies with the immune system status. Seventeen of the selected studies (18 articles) assessed changes in the immune system. The overall percentage of studies reporting an improved exercise performance following flavonoid supplementation was 37%, the proportion being 25% when considering quercetin, 28% for flavanol-enriched extracts, and 54% for anthocyanins-enriched extracts. From the studies reporting an enhanced performance, only two, using anthocyanin supplements, focused on the immune system and found certain anti-inflammatory effects of these flavonoids. These results suggest that flavonoids, especially anthocyanins, may exert beneficial effects for athletes' performances, although further studies are encouraged to establish the optimal dosage and to clarify their impact on immune status.Entities:
Keywords: anthocyanins; cytokines; exhaustion; flavanols; inflammation; quercetin; upper respiratory tract infections
Year: 2021 PMID: 33808153 PMCID: PMC8065858 DOI: 10.3390/nu13041132
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Chemical structures of flavonoids and their classes. Based on reference [1].
Figure 2Flow diagram of the article selection process.
Figure 3Summary of the included studies classified according to the flavonoid subclass and the percentage of studies reporting improvements in exercise performance.
Summary of the included studies assessing the effects of a single flavonoid intervention on exercise performances.
| Reference | Flavonoid | Control Group | Study Design | Number of | Mean Age of | Dosage | Exercise | Performance Variable | Effect |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| [ | Quercetin + | Tang powder | Db | 0 + 40 | 26.1 ± 1.8 (SUP) | 1000 mg/d | Three 3 h | Mean power | NS |
| [ | Quercetin + isoquercetin + EGCG | Placebo +/− | Db | 7 + 32 | 26.3 ± 1.7 (PL) | 1000 mg | Cycling | 5, 10 and 20 km time trials | NS |
| [ | Quercetin + | Sports | Db | 0 + 30 | 23.1 ± 2.4 (SUP) | 1000 mg/d | Cycling | Work performed in a 10 min maximal effort cycling | NS |
| [ | Quercetin + | Tang | Db | 5 + 7 | 22.9 ± 2.4 | 1000 mg/d | Cycling | Time to | Improvement |
| [ | Quercetin + | Placebo chews | Db | 7 + 32 | 44.2 ± 2.0 (SUP) | 1000 mg/d | 160-km Western States | Race time | NS |
| [ | Quercetin + PowerAde | PowerAde | Db | 0 + 26 | 20.2 ± 0.4 | 1000 mg/d | 12 min | Distance | Improvement |
| [ | Quercetin + Isoquercetin + EGCG + | Placebo chews | Db | 14 + 44 | 22.0 ± 5.1 (SUP) | 1000 mg/d | APFT, BMPU, | Time trial, |
|
| [ | Quercetin-3-glucoside + | 6% carbohydrate sports drink | Db | 0 + 15 | 23.3 ± 2.6 | 1000 mg/d | Running repeated sprints | Mean sprint time | NS |
| [ | Quercetin + food bars | Energy bars | Db, RPCCT | 0 + 16 | 22.0 ± 3.0 | 1000 mg/d | Marching in a treadmill and cycling trial | Time trial | NS |
| [ | Quercetin | Placebo +/- | Db, RPCT | 0 + 65 | 21.0 ± 1.6 | 500 mg/d | Running in a treadmill | Time to | NS |
| [ | Quercetin + | Energy bars containing vit C and tocopherols | Db, RPCT | 14 + 16 | 19.6 ± 1.3 (female PL) | 1000 mg/d | Eccentric | Muscle strength, | NS |
| [ | Quercetin | Placebo capsules | RPCCT | 0 + 12 | 26.1 ± 3.1 | 1000 mg/d | Eccentric contractions | Arm angle, arm | Improvement |
|
| |||||||||
| [ | (-)-epicatechin | Cellulose | Db, RPCT | 20 | 20.5 ± 1.5 (SUP) | 200 mg/d | Cycling | Peak anaerobic | Worsening |
| [ | Hesperetin-7-O-rutinoside | Microcrystalline cellulose capsules | Db, RPCT | 0 + 39 | 23.0 ± 0.3 | 500 mg/d | Cycling | Absolute power output | Improvement |
Db = double-blind, RPCT = randomized placebo-controlled trial, RPCCT = randomized placebo-controlled crossover trial, PL= placebo, SUP = flavonoid-supplemented, d = day, wk = week, NS = nonsignificant effect, EGCG = epigallocatechin gallate, EPA = eicosapentaenoic acid, DHA = docosahexaenoic acid, APFT = Army Physical Fitness Test, BMPU = Baumgartner Modified Pull-Up Test, Vit = vitamin, and WAnT = Wingate Anaerobic Test.
Summary of the included studies assessing the effects of flavonoid-enriched extracts on exercise performances.
| Family | Flavonoid | Control Groups | Study Design | Number of | Mean Age of Participants | Dosage | Exercise | Performance Variable | Effect |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| [ | Apple extract (Applephenon®) | Crystalline cellulose | Db | 9 + 9 | 39.1 ± 9.1 | 720 mg/d | Cycling | Change of maximum | Improvement |
| [ | Green tea | Carbohydrate-containing drink | Db | 0 + 9 | 32.2 ± 2.1 | 159 mg/d | Cycling | Time for 30 km trial | NS |
| [ | Green tea | Microcrystal-line cellulose capsules | Db | 0 + 16 | 21.6 ± 1.5 | 800 mg/d | Cycling | Peak power, mean power, total work | NS |
| [ | Decaffeinated green tea extract | Corn flour capsules | Db | 0 + 14 | 21.4 ± 0.3 | 400 mg/d EGCG | Cycling | Distance | Improvement |
| [ | Green tea | Sports drink | Db | 0 + 14 | 33.9 ± 7.4 | 570 mg/d catechins | Cycling | Leg extension strength | Improvement |
| [ | Green tea | Starch | Db | 0 + 40 | 21.0 ± 1.0 | 207 mg/d catechins | Running | Time to | NS |
| [ | Blueberry-green tea-polyphenol soy protein | Soy protein complex with non-polyphenolic food coloring | Db | 13 + 18 | 33.7 ± 6.8 (SUP) | 1001 mg/d | Running in a treadmill for 2.5 h | Distance | NS |
| [ | Green tea | Microcrystalline cellulose capsules | Db | 0 + 40 | 23.3 ± 4.1 (CT) | 800 mg/d | Maximal strength | Strength | NS |
| [ | Green tea | Celulomax® capsules | Tb RPCT | 0 + 20 | 25 ± 5 | 18.5 mg/d catechins | Calf-rising exercise | Number of repetitions | NS |
| [ | Flavanol-rich lychee fruit | Malt extract | Db RPCT | 0 + 20 | 20.6 ± 1.3 (SUP) | 100 mg/d | Running training, combining low, | Time for | NS |
| [ | Oligomerized lychee fruit | Dextrin capsules | Db RPCT | 0 + 38 | 24.6 ± 6.6 (SUP) | 200 mg/d flavanols | Running | Submaximal running time | Improvement |
| [ | Nonalcoholic | Control beverage containing the same ingredients except for polyphenols | Db RPCT | 0 + 121 | 44 (SUP) | 1.0–1.5 L/d with 47 mg/L catechin and 33 mg/L | Munich | Time for | NS |
| [ | Dark | Isocaloric control chocolate without polyphenols | Sb RPCCT | 0 + 20 | 22.0 ± 4.0 | 197.4 mg of | Incremental cycling | Time to | NS |
| [ | Cocoa | Maltodextrin capsules containing the same amount of theobromine and caffeine than cocoa | Db RPCT | 0 + 14 | 30.7 ± 3.1 | 100 mg epicatechin and 23 mg catechin | Cycling trial in | Completed work in 20 min cycling trial | NS |
| [ | Dark | Isocaloric nonchocolate placebo | Db RPCCT | 2 + 10 | 35.0 ± 12.0 | 60 g/d dark chocolate for 14 d and 120 g just before trial | 10 km | Time trial | NS |
| [ | Cocoa | Chocolate milk | Db RPCT | 0 + 13 | 20.69 ± 1.49 | 308 mg/d | Vertical-jump and yo-yo tests | Vertical jump performance, accumulated distance | NS |
| [ | Cocoa | Maltodextrin | Db RPCT | 0 + 32 | 33 ± 7 (SUP) | 425 mg/d flavanols | Treadmill running | Time to run | NS |
| [ | Carob | Carob- | Db RPCT | 11 + 12 | 21.91 ± 1.22 | 14.4 mg/d | Taekwondo training + | Distance covered, maximal aerobic | Improvement |
|
| |||||||||
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystal-line cellulose capsules | Db | 0 + 14 | 38.0 ± 13.0 | 105 mg/d | Cycling trial | Time trial | Improvement |
| [ | Blackcurrant | Orange | Db | 23 + 0 | 31.0 ± 8.0 | 300 mg/d | Running test | Time trial | Worse for average |
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystal-line cellulose capsules | Db | 0 + 13 | 25.0 ± 4.0 | 105 mg/d | Treadmill running | Running distance | Improvement |
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystalline cellulose capsules | Db | 8 + 12 | 30.0 ± 6.0 | 210 mg/d | Chichester half- | Finish time | NS |
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystal-line cellulose capsules | Db | 0 + 13 | 25 ± 4 | 210 mg/d | Submaximal isometric | Isometric maximal voluntary contractions | NS |
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystal-line cellulose capsules | Db | 0 + 12 | 25.0 ± 4.0 | 210 mg/d | Submaximal forearm muscle contractions | Maximal | NS |
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystal-line cellulose capsules | Db | 0 + 12 | 26.0 ± 5.0 | 210 mg/d | Submaximal forearm muscle contractions | Time to | NS |
| [ | New Zealand blackcurrant (CurraNZ™) | Microcrystal-line cellulose capsules | Db | 0 + 18 | 24.0 ± 6.0 | 210 mg/d | Climbing ability test | Time to | Improvement |
| [ | Montmorency | Commercially cordial with less than 5% fruit, mixed with water and maltodextrin | Db | 0 + 16 | 30.0 ± 8.0 | 547.02 mg/d | Cycling trial | Work | NS |
| [ | Montmorency | Dextrose capsules | Db | 0 + 8 | 19.7 ± 1.6 | 256.8 mg/d | Cycling time trial | Time trial completion time | Improvement |
| [ | Montmorency | Rice flour capsules | Db | 9 + 18 | 21.8 ± 3.9 | 66 mg/d | Running (half- | Finish time | Improvement |
| [ | Integral purple grape juice | Isoenergetic carbohydrate-based beverage | Db | 6 + 22 | 39.8 ± 8.5 | 10 mL/kg/d containing 52.6 mg/L anthocyanins | Treadmill running | Time to | Improvement |
| [ | Blueberry | Carbohydrate and fiber-matched placebo | Db | 0 + 59 | 39.0 ± 2.0 | 345 mg/d | Cycling | Time trial | NS |
|
| |||||||||
| [ | Pomegranates | Carbohydrate-matched placebo drink | Db | 0 + 12 | 26.8 ± 5.0 | 171.9 mg/d | Cycling in the heat | Time trial | NS |
| [ | Pomegranate extract | Pure stevia extract | Db | 2 + 6 | 37 ± 11 | 15 mg/kg/d | Cycling time trial | Average power outputs and energy | NS |
| [ | Pomegranate extract (POMANOX® P30) | Maltodextrin capsules | Db | 0 + 24 | 34.9 ± 10 | 225 mg/d | Cycling trial | Time to | Improvement |
| [ | Pomegranate juice | Water, sugar, and | Db | 0 + 19 | 20.8 ± 0.86(SUP) 20.9 ± 0.95(PL) | 50 mL/d juice containing 220 mg/100 g polyphenols | Rowing | Time to | NS |
|
| |||||||||
| [ | Peptides, taurine, | Starch and lactose | Db | 0 + 14 | 21.6 ± 0.7 | 180 mg of | Cycling | Time to | Improvement |
|
| |||||||||
| [ | Peanut husk extract | Microcrystal-line cellulose capsules containing maltodextrin | Db | 0 + 12 | 21.3 ± 2.1 | 50 or 100 mg/d | Cycling trial | Peak power | Improvement |
Tb = triple-blind, Db = double-blind, Sb = single-blind, RCT = randomized controlled trial, RPCT = randomized placebo-controlled trial, RPCCT = randomized placebo-controlled crossover trial. LD = low-dose, HD = high-dose, PL= placebo, SUP = flavonoid-supplemented, d = day, wk = week, and NS = nonsignificant effect.
Figure 4Risk of bias graph: review authors’ judgments about each risk of bias item presented as percentages across all included studies.
Summary of the included studies assessing the association between flavonoid intake, exercise performance, and immune status biomarkers in humans.
| Reference | Flavonoid | Dosage | Exercise | Effect on | Measurement | Outcome |
|---|---|---|---|---|---|---|
|
| ||||||
| [ | quercetin + | 1000 mg/d | Three 3-h | NS |
plasma inflammatory cytokines (IL-6, IL-10, IL-1ra, IL-8, MCP-1, TNF-α) leukocyte mRNA muscle mRNA |
= plasma inflammatory cytokines ↓ leukocyte gene expression of IL-8 and IL-10 |
| [ | quercetin + | 1000 mg/d | Three 3-h | NS |
NK cell activity proliferative activity PMN oxidative-burst activity salivary IgA incidence of URTI |
= NK cell activity = proliferative activity = PMN oxidative-burst activity = IgA ↓ incidence of URTI |
| [ | quercetin + | 1000 mg/d quercetin + | 160-km | NS |
CRP Plasma inflammatory cytokines (IL-1Ra, IL-6, IL-8, IL-10, G-CSF, MCP-1, MIP-1β, TNF-α, MIF-1) leukocyte gene expression of some cytokines |
= CRP = plasma inflammatory cytokines = leukocyte gene expression |
| [ | quercetin-3- | 1000 mg/d | Running | NS |
plasma IL-6 |
= plasma IL-6 |
| [ | Quercetin + isoquercetin + EGCG | 1000 mg quercetin + | Cycling | NS |
plasma CRP plasma IL-6 and IL-10 blood leukocyte counts salivary IgA |
= plasma CRP = plasma IL-6 and IL-10 ↓ blood leukocyte counts = salivary IgA |
| [ | Quercetin + | 1000 mg/d quercetin + 20 mg/d vit C + 14 mg/d tocopherols | Eccentric | NS |
plasma IL-6 plasma CRP |
= IL-6 = CRP |
|
| ||||||
| [ | Green tea extract | 159 mg/d | Cycling | NS |
plasma IL-6 plasma CRP |
= IL-6 ↓ CRP |
| [ | Blueberry–green tea–polyphenol soy protein | 1001 mg/d | Running in a treadmill | NS |
WBC count serum CRP plasma IL-6, MCP-1 |
= WBC = CRP = plasma IL-6, MCP-1 |
| [ | Blueberry–green tea–polyphenol soy protein | 1001 mg/d | Running in a treadmill | NS |
ex vivo antibacterial activity ex vivo antiviral activity |
= ex vivo antibacterial activity ↑ ex vivo antiviral activity |
| [ | Flavanol-rich | 100 mg/d | Running training, combining low, medium, and high intensities | NS |
Total and differential WBC counts CRP serum inflammatory (IL-6) and anti-inflammatory cytokines (IL-10, TFG-β1, TFG-β2) |
↓ WBC counts, = neutrophil and lymphocyte counts = CRP = absolute IL-6, IL-10, TFG-β1, TFG-β2 ↓ % IL-6 and TFG-β1 from pre-training to mid-training period |
| [ | Nonalcoholic beer | 1.0–1.5 L/d with | Munich | NS |
IL-6 CRP total blood leukocyte counts incidence of URTI |
↓ IL-6 ↓ CRP ↓ WBC ↓ URTI incidence |
| [ | Dark chocolate | 197.4 mg | Incremental | NS |
inflammatory and anti- inflammatory cytokines WBC, neutrophil counts |
= IL-6, IL-1ra, IL-10 = WBC, neutrophil counts |
|
| ||||||
| [ | New Zealand blackcurrant | 210 mg/d | Chichester | NS |
urine IL-6 |
= urine IL-6 |
| [ | Montmorency | 547.02 mg/d | Cycling trial | NS |
hs-CRP blood inflammatory cytokines |
↓ hs-CRP ↓ IL-6 = IL-1β, IL-8, TNFα |
| [ | Montmorency | 66 mg/d | Running (half-marathon) | Improvement |
serum inflammatory cytokines (TNF α, IFN-γ, IL-1β, IL-2, IL-6, IL-8, IL-12p70) serum anti-inflammatory cytokines (IL-4, IL-5, IL-7, IL-10, IL-13) total and differential WBC GM-CSF |
↓ IL-6, ↓ IL-2, = remaining cytokines ↓ IL-13, = remaining cytokines = WBC = GM-CSF. |
| [ | Integral purple grape juice | 10 mL/kg/d containing 52.6 mg/L | Treadmill running | Improvement |
serum AGP hs-CRP WBC |
↓ AGP = hs-CRP = WBC |
| [ | Blueberry | 345 mg/d | Cycling | NS |
Inflammatory cytokines Oxylipins |
= IL-6, IL-1ra ↓ some oxylipins |
|
| ||||||
| [ | Pomegranate juice | 50 mL/d juice containing 220 mg/100 g polyphenols | Rowing | NS |
Serum inflammatory cytokines |
= IL-6, IL-1ra |
↓ = decrease, ↑ = increase, AGP = α-1-acid glycoprotein, CRP = plasma C-reactive protein, GM-CSF = granulocyte colony-stimulating factor, hs= high-sensitivity, IFN = interferon, IgA = immunoglobulin A, IL = interleukin, MCP-1 = monocyte chemoattractant protein-1, NK = natural killer, PMN = polymorphonuclear leukocytes, TGF = transforming growth factor, TNF = tumor necrosis factor, URTI = upper-respiratory tract infections, vit = vitamin, WBC = white blood cells.